Catherine Willmott has an M.S. degree in clinical neuropsychology (University of Melbourne, VIC, Australia) and a Ph.D. degree (Monash University, VIC, Australia) investigating the efficacy of methylphenidate in the rehabilitation of attention deficits following traumatic brain injury (TBI). She is currently a Lecturer and Clinic Coordinator at the Doctor of Psychology (clinical neuropsychology) program in the School of Psychology and Psychiatry at Monash University. Dr. Willmott has conducted research into the rehabilitation of adult and pediatric traumatic brain injury (TBI) populations for the past 18 years. In the 1990s, she was involved in studies identifying the contribution of factors to ongoing symptoms following mild TBI in adults and children. This involved developing and evaluating information booklets for mild TBI patients, now used internationally and translated into 5 languages, and validated a revised version of the Westmead PTA Scale for screening mild TBI patients in the emergency departments. Dr. Willmott has conducted research into cognitive problems associated with moderate-severe TBI, particularly deficits in attention and information processing speed, in adult and pediatric populations. More recently, she investigated the efficacy of methylphenidate in the remediation of attention deficits in acute TBI rehabilitation, funded by the Victorian Neurotrauma Initiative. The study resulted in a number of publications in journals with relatively high impact factors. Dr. Willmott is a registered Psychologist with the Psychology Board of Australia and an active Member of the following societies: Australian Psychological Society, College of Clinical Neuropsychologists (APS-CCN); The International Neuropsychological Society (INS); the Australian Society for the Study of Brain Impairment (ASSBI). Since 2005, she has served as an external Reviewer for the Journal of the International Neuropsychological Society.
Biography Updated on 8 December 2011